Clinical Trial Update: Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating how empagliflozin pharmacokinetics affect renal glucose reabsorption in adults with type 2 diabetes and in healthy co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2, Healthy | Phase 2 | Status: COMPLETED | Results posted: 2017-05-11